The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease (PS1V97L)

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2018-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-171094PMID 29614686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Ageing and Oxidative Stress in Regulation of Amyloid-Degrading Enzymes and Development of Neurodegeneration.

  2017cited by this paper
• Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.

  2016cited by this paper
• Cerebrovascular pathology and Alzheimer's disease.

  2016cited by this paper
• Severe chronic cerebral hypoperfusion induces microglial dysfunction leading to memory loss in APPswe/PS1 mice

  2016cited by this paper
• Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study

  2016cited by this paper
• Cerebrovascular disease in ageing and Alzheimer’s disease

  2015cited by this paper
• The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease

  2015cited by this paper
• Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes

  2014cited by this paper
• IMM‐H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA‐and PI3K‐dependent Akt activation

  2014cited by this paper
• Effect of Transient Cerebral Ischemia on the Expression of Receptor for Advanced Glycation End Products (RAGE) in the Gerbil Hippocampus Proper

  2014cited by this paper
• A Lifespan Observation of a Novel Mouse Model: In Vivo Evidence Supports Aβ Oligomer Hypothesis

  2014cited by this paper
• Amyloid β-protein oligomers and Alzheimer’s disease

  2013cited by this paper
• The pathobiology of vascular dementia.

  2013cited by this paper
• Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series

  2013cited by this paper
• Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia.

  2012cited by this paper
• Val97Leu mutant presenilin‐1 induces tau hyperphosphorylation and spatial memory deficit in mice and the underlying mechanisms

  2012cited by this paper
• Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion.

  2012cited by this paper
• Bihemispheric Cerebral FDG PET Correlates of Cognitive Dysfunction as Assessed by the CERAD in Alzheimer's Disease

  2011influential reference
• Time Course of Glucose Metabolism in Relation to Cognitive Performance and Postmortem Neuropathology in Met146Val PSEN1 Mutation Carriers

  2011influential reference
• Prevalence of dementia disorders in the oldest-old: an autopsy study

  2010cited by this paper
• The role of low-density receptor-related protein 1 (LRP1) as a competitive substrate of the amyloid precursor protein (APP) for BACE1.

  2010cited by this paper
• Experimental models of vascular dementia and vascular cognitive impairment: a systematic review

  2010cited by this paper
• Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus.

  2009cited by this paper
• Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease

  2009cited by this paper
• Changing perspectives regarding late-life dementia

  2009cited by this paper
• Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice.

  2008cited by this paper
• Hippocampal hypometabolism predicts cognitive decline from normal aging.

  2008cited by this paper
• Mixed brain pathologies account for most dementia cases in community-dwelling older persons

  2007cited by this paper
• Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.

  2007cited by this paper
• Tissue-Type Plasminogen Activator and the Low-Density Lipoprotein Receptor-Related Protein Mediate Cerebral Ischemia-Induced Nuclear Factor-κB Pathway Activation

  2007cited by this paper
• Effects of Hypoxia and Oxidative Stress on Expression of Neprilysin in Human Neuroblastoma Cells and Rat Cortical Neurones and Astrocytes

  2007cited by this paper
• Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function*

  2006cited by this paper
• Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels.

  2006cited by this paper
• Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.

  2006cited by this paper
• RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

  2006cited by this paper
• Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study

  2005cited by this paper
• One novel presenilin-1 gene mutation in a Chinese pedigree of familial Alzheimer's disease

  2005cited by this paper
• Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase.

  2005cited by this paper
• Low Density Lipoprotein Receptor-related Protein (LRP) Interacts with Presenilin 1 and Is a Competitive Substrate of the Amyloid Precursor Protein (APP) for γ-Secretase*

  2005cited by this paper
• Effect of Hypoxia/Ischemia and Hypoxic Preconditioning/Reperfusion on Expression of Some Amyloid‐Degrading Enzymes

  2004cited by this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cited by this paper
• Mixed Dementia—the Most Common Cause of Dementia

  2002cited by this paper
• Metabolic regulation of brain Abeta by neprilysin.

  2001cited by this paper
• Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.

  2001cited by this paper
• Metabolic Regulation of Brain Aβ by Neprilysin

  2001cited by this paper
• Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging.

  2001cited by this paper
• Dynamic Imaging of Cerebral Blood Flow Using Laser Speckle

  2001cited by this paper
• LRP: a multifunctional scavenger and signaling receptor.

  2001cited by this paper
• Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

  2000cited by this paper
• Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.

  2000cited by this paper
• Differentiation of vascular dementia from AD on neuropsychological tests

  1999cited by this paper
• Laser speckle contrast analysis (LASCA): a nonscanning, full-field technique for monitoring capillary blood flow.

  1996cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism

  1995cited by this paper
• Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism.

  1995cited by this paper
• Cerebrovascular Permeability to Peptides: Manipulations of Transport Systems at the Blood-Brain Barrier

  1995cited by this paper

• Sex-Specific Adaptations in Alzheimer’s Disease and Ischemic Stroke: A Longitudinal Study in Male and Female APPswe/PS1dE9 Mice

  2025cites this paper
• Relationship between extracranial carotid artery calcification and amyloid-β deposition in the brain among the very old: A retrospective study

  2025influential citation
• Pulse pressure as a predictor of Alzheimer’s disease biomarkers and cognitive decline: The moderating role of APOE ε4

  2025cites this paper
• The pathophysiology of mixed Alzheimer's disease and vascular dementia

  2025cites this paper
• The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer’s disease

  2024cites this paper
• RAGE: a potential target for Epimedium’s anti-neuroinflammation role in vascular dementia—insights from network pharmacology and molecular simulation

  2023cites this paper
• RAGE acted as a new anti-inflammatory target for Icariin’s treatment against vascular dementia based on network pharmacology-directed verification

  2023cites this paper
• The Association Between 24-Hour Blood Pressure Profiles and Dementia

  2023cites this paper
• Can Exercise Training Teach Us How to Treat Alzheimer's disease?

  2022cites this paper
• Haemodynamic impairment along the Alzheimer’s disease continuum

  2021cites this paper
• Potent therapeutic targets for treatment of Alzheimer's disease: Amyloid degrading enzymes

  2021cites this paper
• A Fundamental Role for Oxidants and Intracellular Calcium Signals in Alzheimer’s Pathogenesis—And How a Comprehensive Antioxidant Strategy May Aid Prevention of This Disorder

  2021cites this paper
• Role of HMGB1 in an Animal Model of Vascular Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion

  2020cites this paper
• Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

  2020cites this paper
• The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer’s Disease Mouse Model (PS1V97L)

  2020influential citation
• Impaired amyloid beta clearance and brain microvascular dysfunction are present in the Tg-SwDI mouse model of Alzheimer's disease.

  2020cites this paper
• The role of high-mobility group box protein 1 in chronic cerebral hypoperfusion-induced vascular cognitive impairment animals

  2019influential citation
• Pre-Clinical Safety and Efficacy Evaluation of Amytrap, a Novel Therapeutic to Treat Alzheimer’s Disease

  2019cites this paper
• Clinical and Pathological Benefits of Edaravone for Alzheimer’s Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model

  2019cites this paper
• Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy

  2019cites this paper